SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1981; 7: 1633-1638.
  • 2
    Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1980; 6: 1-9.
  • 3
    Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys. 1991; 20: 53-58.
  • 4
    Phillips TL, Scott CB, Leibel SA, Rotman M, Weigensberg IJ. Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys. 1995; 33: 339-348.
  • 5
    Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev. 2006; 3: CD003869.
  • 6
    Kano H, Iyer A, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Outcome predictors of Gamma Knife radiosurgery for renal cell carcinoma metastases. Neurosurgery. 2011; 69: 1232-1239.
  • 7
    Kondziolka D, Kano H, Harrison GL, et al. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. J Neurosurg. 2011; 114: 792-800.
  • 8
    Liew DN, Kano H, Kondziolka D, et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg. 2011; 114: 769-779.
  • 9
    Flannery T, Kano H, Niranjan A, et al. Gamma knife radiosurgery as a therapeutic strategy for intracranial sarcomatous metastases. Int J Radiat Oncol Biol Phys. 2010; 76: 513-519.
  • 10
    Monaco E 3rd, Kondziolka D, Mongia S, Niranjan A, Flickinger JC, Lunsford LD. Management of brain metastases from ovarian and endometrial carcinoma with stereotactic radiosurgery. Cancer. 2008; 113: 2610-2614.
  • 11
    Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg. 2002; 97: 1276-1281.
  • 12
    Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999; 45: 427-434.
  • 13
    Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys. 2006; 64: 898-903.
  • 14
    Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006; 295: 2483-2491.
  • 15
    Burger PC, Mahley MS Jr, Dudka L, Vogel FS. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer. 1979; 44: 1256-1272.
  • 16
    Hopewell JW. Late radiation damage to the central nervous system: a radiobiological interpretation. Neuropathol Appl Neurobiol. 1979; 5: 329-343.
  • 17
    Tiller-Borcich JK, Fike JR, Phillips TL, Davis RL. Pathology of delayed radiation brain damage: an experimental canine model. Radiat Res. 1987; 110: 161-172.
  • 18
    van der Kogel AJ. The nervous system: radiobiology and experimental pathology. In: Scherer E, Streffer C, Trott KR, eds. Radiopathology of Organs and Tissues. Berlin, Germany: Springer Verlag; 1991: 191-212.
  • 19
    Panagiotakos G, Alshamy G, Chan B, et al. Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS One. 2007; 2( 7): e588.
  • 20
    Carmichael O, Schwarz C, Drucker D, et al. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol. 2010; 67: 1370-1378.
  • 21
    Breteler MM, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke. 1994; 25: 1109-1115.
  • 22
    Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987; 149: 351-356.
  • 23
    Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol. 2005; 28: 173-179.
  • 24
    Fujii O, Tsujino K, Soejima T, Yoden E, Ichimiya Y, Sugimura K. White matter changes on magnetic resonance imaging following whole-brain radiotherapy for brain metastases. Radiat Med. 2006; 24: 345-350.
  • 25
    Tsuruda JS, Kortman KE, Bradley WG, Wheeler DC, Van Dalsem W, Bradley TP. Radiation effects on cerebral white matter: MR evaluation. AJR Am J Roentgenol. 1987; 149: 165-171.
  • 26
    Szerlip N, Rutter C, Ram N, et al. Factors impacting volumetric white matter changes following whole brain radiation therapy. J Neurooncol. 2011; 103: 111-119.
  • 27
    Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007; 7: 192-201.
  • 28
    Regine WF, Scott C, Murray K, Curran W. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys. 2001; 51: 711-717.
  • 29
    Caveness WF. Experimental observations: delayed necrosis in normal monkey brain. In: Gilbert HA, Kagan AR, eds. Radiation Damage to the Nervous System: A Delayed Therapeutic Hazard. New York, NY: Raven; 1980: 1-38.
  • 30
    Denekamp J, Fowler JF. Cell proliferation kinetics and radiation therapy. In: Becker FF, ed. Cancer: A Comprehensive Treatise. New York, NY: Plenum; 1975: 101-137.
  • 31
    Groothuis DR, Vick N. Radionecrosis of the central nervous system: the persective of the clinical neurologist and neuropathologist. In: Gilbert HA, Kagan AR, eds. Radiation Damage to the Nervous System: A Delayed Therapeutic Hazard. New York, NY: Raven; 1980: 93-106.
  • 32
    Curnes JT, Laster DW, Ball MR, Moody DM, Witcofski RL. MRI of radiation injury to the brain. AJR Am J Roentgenol. 1986; 147: 119-124.
  • 33
    Nieder C, Leicht A, Motaref B, Nestle U, Niewald M, Schnabel K. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol. 1999; 22: 573-579.
  • 34
    Shibamoto Y, Baba F, Oda K, et al. Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study. Int J Radiat Oncol Biol Phys. 2008; 72: 1168-1173.
  • 35
    Conill C, Berenguer J, Vargas M, et al. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol. 2007; 9: 590-595.
  • 36
    O'sullivan M, Jones DK, Summers PE, Morris RG, Williams SC, Markus HS. Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline. Neurology. 2001; 57: 632-638.
  • 37
    Merchant TE, Kiehna EN, Li C, Xiong X, Mulhern RK. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys. 2005; 63: 1546-1554.
  • 38
    Rutkowski S. Current treatment approaches to early childhood medulloblastoma. Expert Rev Neurother. 2006; 6: 1211-1221.
  • 39
    DeAngelis LM, Currie VE, Kim JH, et al. The combined use of radiation therapy and lonidamine in the treatment of brain metastases. J Neurooncol. 1989; 7: 241-247.
  • 40
    Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007; 68: 1388-1395.
  • 41
    Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009; 10: 1037-1044.
  • 42
    Nakaya K, Hori T, Izawa M, Yamamoto M. Gamma knife radiosurgery for 10 or more brain metastases: Analysis of whole brain irradiation doses. Tokyo Joshi Ikadaugaku Zasshi. 2002; 72: 18-23.